Latest News
Why Shares of Phibro Animal Health Are Dropping This Week
The company's shares have been slipping since it announced fiscal 2023 fourth-quarter earnings.
TerraCycle Appoints New Chief Financial Officer to Global Leadership Team
/PRNewswire/ -- TerraCycle Inc., the international leader in innovative sustainability solutions, today announced Damian Finio will join the company's global...
Phibro Issues Second Environmental, Social and Governance Report
Phibro Animal Health Corporation (Nasdaq: PAHC) is a global leader in animal health and mineral nutrition. We partner with livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals. We provide...
Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter and year-to-date ended March 31, 2023.
Phibro Animal Health Corporation Declares Quarterly Dividend
The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 28, 2023, to stockholders of record at the...
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Financial Results
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 3, 2023, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 4, 2023, at 9:00...
Phibro Animal Health Corporation to Participate in Bank of America Securities 2023 Health Care Conference.
Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America Securities 2023 Health Care Conference.
We are looking for companies with sustainable dividends spurred by the pandemic-induced boom in pet ownership
Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference
Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Barclays Global Healthcare Conference.
Phibro Animal Health Corporation to Participate in Bank of America 2023 Animal Health Summit
Phibro Animal Health Corporation (Nasdaq:PAHC) announced today it will participate in the Bank of America 2023 Virtual Animal Health Summit.
Phibro Animal Health Corporation Reports Second Quarter Results
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2022.
Phibro Animal Health Corporation Announces the Appointment of Alejandro Bernal to Its Board of Directors and Declares Quarterly Dividend
The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Alejandro Bernal, DVM, MS, MBA, as a Class III director of the Company, effective immediately. Mr. Bernal will be an independent director....
Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2022 Quarterly Financial Results
Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its second quarter financial results on Wednesday, February 8, 2023, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 9,...
Phibro Animal Health Corporation Reports First Quarter Results, Revised Guidance
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2022, and reiterated its financial guidance for Net sales and Adjusted EBITDA and revised its...
Phibro Animal Health Corporation Declares Quarterly Dividend
The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 21, 2022, to stockholders of record at...
Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2022 Quarterly Financial Results
Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its first quarter financial results on Wednesday, November 9, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 10,...
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
Phibro Animal Health Corporation (Nasdaq:PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided financial guidance for the year ending June 30, 2023.
Phibro Animal Health Corporation to Participate in Morgan Stanley Global Healthcare Conference
Phibro Animal Health Corporation (Nasdaq:PAHC) announced today it will participate in the Morgan Stanley Global Healthcare Conference being held at the Sheraton New York.
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2022 Results
Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its fourth quarter and fiscal year 2022 financial results on Wednesday, August 24, 2022, after the market closes. Phibro management will host a conference call and webcast on...
Phibro Animal Health Corporation Declares Quarterly Dividend
The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 28, 2022, to stockholders of record at...
Phibro Animal Health Corporation and Rejuvenate Bio Announce Agreement to Develop Gene Therapy for Mitral Valve Disease in Canines
Phibro Animal Health Corporation (Nasdaq:PAHC) and Rejuvenate Bio, Inc. today announced a collaboration for the development and commercialization of a gene therapy for Mitral Valve Disease (MVD) in canines (dogs).
Phibro Issues Inaugural Environmental, Social and Governance Report
Phibro Animal Health Corporation (Nasdaq: PAHC), a diversified global developer, manufacturer, and supplier of a broad range of animal health and mineral nutrition products for livestock, published its inaugural Environmental, Social and...
Phibro Animal Health Corporation Reports Third Quarter Results, Provides Revised Financial Guidance
Phibro Animal Health Corporation (Nasdaq: PAHC) today announced financial results for its third quarter ended March 31, 2022.
Phibro Animal Health Corporation Declares Quarterly Dividend
The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 22, 2022, to stockholders of record at the...
Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2022 Quarterly Financial Results
Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its third quarter financial results on Wednesday, May 4, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 5, 2022, at 9:00...